Posted by Michael Wonder on 16 Dec 2016
Advanced Accelerator Applications announces European Commission approval of SomaKit TOC
15 December 2016 - AAA today announced that following a positive opinion issued by the EMA in October 2016, the European Commission has approved SomaKit TOC 40 μg, a kit for radiopharmaceutical preparation of gallium (Ga 68) edotreotide solution for injection, for positron emission tomography imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumours for localising primary tumours and their metastases.
The drug has 10-year orphan market exclusivity in the European territory.
